FI852610A0 - Dihydropyridiner innehaollande fasta laekemedelsprodukter och foerfarande foer deras framstaellning. - Google Patents

Dihydropyridiner innehaollande fasta laekemedelsprodukter och foerfarande foer deras framstaellning.

Info

Publication number
FI852610A0
FI852610A0 FI852610A FI852610A FI852610A0 FI 852610 A0 FI852610 A0 FI 852610A0 FI 852610 A FI852610 A FI 852610A FI 852610 A FI852610 A FI 852610A FI 852610 A0 FI852610 A0 FI 852610A0
Authority
FI
Finland
Prior art keywords
laekemedelsprodukter
dihydropyridiner
innehaollande
fasta
foerfarande foer
Prior art date
Application number
FI852610A
Other languages
English (en)
Other versions
FI852610L (fi
Inventor
Wolfgang Schmidt
Helmut Luchtenberg
Eduard Porges
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6239792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI852610(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI852610A0 publication Critical patent/FI852610A0/fi
Publication of FI852610L publication Critical patent/FI852610L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Plant Substances (AREA)
FI852610A 1984-07-04 1985-07-02 Dihydropyridiner innehaollande fasta laekemedelsprodukter och foerfarande foer deras framstaellning. FI852610L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843424553 DE3424553A1 (de) 1984-07-04 1984-07-04 Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FI852610A0 true FI852610A0 (fi) 1985-07-02
FI852610L FI852610L (fi) 1986-01-05

Family

ID=6239792

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852610A FI852610L (fi) 1984-07-04 1985-07-02 Dihydropyridiner innehaollande fasta laekemedelsprodukter och foerfarande foer deras framstaellning.

Country Status (15)

Country Link
EP (1) EP0167909B2 (fi)
JP (1) JPH0665644B2 (fi)
KR (1) KR920006908B1 (fi)
AT (1) ATE71297T1 (fi)
AU (1) AU570328B2 (fi)
CA (1) CA1255597A (fi)
DE (2) DE3424553A1 (fi)
DK (1) DK304485A (fi)
ES (1) ES8607018A1 (fi)
FI (1) FI852610L (fi)
GR (1) GR851617B (fi)
HU (1) HU197844B (fi)
IL (1) IL75686A (fi)
PT (1) PT80752B (fi)
ZA (1) ZA855017B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US5015479A (en) * 1987-02-02 1991-05-14 Seamus Mulligan Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine
US5001139A (en) * 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
DE69630878T2 (de) * 1995-03-29 2004-11-11 Shionogi & Co., Ltd. Gelatinekapsel mit eingestellter wasseraktivität
CO4771151A1 (es) * 1996-01-19 1999-04-30 Rachitzky Falicman Pablo Alberto Procedimiento para la elaboracion de una preparacion farmace utica que contiene nifedipina y la preparacion farmaceutica obtenida mediante el mismo
WO2002043704A1 (en) 2000-12-01 2002-06-06 Kyowa Hakko Kogyo Co., Ltd. Composition improved in solubility or oral absorbability
DE10117049A1 (de) * 2001-04-05 2002-10-17 Novartis Ag Zusammensetzung
JP5072748B2 (ja) * 2007-07-10 2012-11-14 株式会社 メドレックス アムロジピンの安定な液剤とゼリー剤
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
DE3142853A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit nifedipin und verfahren zu ihrer herstellung
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
DE3376198D1 (en) * 1983-11-30 1988-05-11 Siegfried Ag Therapeutic coronary composition in the form of soft gelatine capsules
DE3427402A1 (de) * 1984-07-25 1986-01-30 Bayer Ag, 5090 Leverkusen Neues kombinationspraeparat, verfahren zu seiner herstellung und seine verwendung als arzneimittel

Also Published As

Publication number Publication date
GR851617B (fi) 1985-11-26
JPS6118725A (ja) 1986-01-27
KR860000864A (ko) 1986-02-20
EP0167909B1 (de) 1992-01-08
ES544787A0 (es) 1986-06-16
DK304485A (da) 1986-01-05
AU4429885A (en) 1986-01-09
PT80752A (en) 1985-08-01
EP0167909B2 (de) 1994-10-19
CA1255597A (en) 1989-06-13
EP0167909A2 (de) 1986-01-15
ZA855017B (en) 1986-02-26
EP0167909A3 (en) 1987-10-14
FI852610L (fi) 1986-01-05
DE3424553A1 (de) 1986-01-09
DK304485D0 (da) 1985-07-03
IL75686A (en) 1988-11-30
IL75686A0 (en) 1985-11-29
KR920006908B1 (ko) 1992-08-22
HUT41259A (en) 1987-04-28
AU570328B2 (en) 1988-03-10
ATE71297T1 (de) 1992-01-15
DE3585107D1 (de) 1992-02-20
ES8607018A1 (es) 1986-06-16
JPH0665644B2 (ja) 1994-08-24
PT80752B (pt) 1987-10-20
HU197844B (en) 1989-06-28

Similar Documents

Publication Publication Date Title
FI885369A0 (fi) Ny mattbotten och monteringsfoerfarande.
FI880305A0 (fi) Ny, faergbar gatubelaeggning.
FI893691A0 (fi) Ny injektionsspruta.
FI852610A0 (fi) Dihydropyridiner innehaollande fasta laekemedelsprodukter och foerfarande foer deras framstaellning.
DE3870959D1 (de) 2-difluormethoxy-1,1,1,2-tetrafluoraethan als anaesthetikum.
DE68923797D1 (de) Skalpell.
FI913787A0 (fi) Papiljott.
DE69006657D1 (de) Gebläse.
FI891899A0 (fi) Ny biotest.
DE58909374D1 (de) Lüfter.
DE59000162D1 (de) Betaetigungshandhabe.
FI862642A0 (fi) 3-(substituerade) propenylaminotiazol-yl-kefalosporansyror och deras estrar.
FI892985A0 (fi) Ny polypeptid och anvaendning daerav.
NO864456D0 (no) Stiftemaskin.
ATA95689A (de) Maeh- bzw. haeckselmaschine
DE69010198D1 (de) Rasierverfahren.
TR23713A (tr) Suebstituye edilmis tiouereler,izotiouereler ve korbadiimetiller
FI891353A0 (fi) Bytesmekanism foer radioaktiva prov i en foer massaundersoekningar avsedd gammaraeknare.
NL191828C (nl) Haarimplanteerinrichting.
FI874083A0 (fi) 2-hydrokarbyl-3,6-diklorpyridiner och deras framstaellning.
ES1010547Y (es) Identificador personal y de empresa.
FI890816A (fi) Anordning i kantpress.
FI895059A0 (fi) Ny doseringsform.
ATE68392T1 (de) Schere.
FI874963A0 (fi) Ny, faergbar gatubelaeggning.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT